Showing results (171-180 of 329) with videos related to

Sort By:
Pageof 33
Journal of Pharmaceutical and Biomedical Analysis|October 1, 1995
The secretion of propranolol enantiomers in human saliva: evidence for active transport?K M Höld, D de Boer, J R Soedirman, et al.
Archives of Toxicology|October 20, 1975
The effect of magnesium sulfate on the absorption of acetylsalicylic acid and lithium carbonate from the human intestineP N Sorensen, S Lindkaer-Jensen, A Dijk, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 1, 1992
The methyl-5 alpha-dihydrotestosterones mesterolone and drostanolone; gas chromatographic/mass spectrometric characterization of the urinary metabolitesD de Boer, E G de Jong, R A Maes, et al.
American Journal of Nephrology|January 1, 1990
Streptomycin pharmacokinetics in relapsing Mycobacterium xenopi peritonitisJ J Sennesael, V A Maes, D Pierard, et al.
Archives of Toxicology|April 1, 1985
An evaluation of the efficacy of charcoal haemoperfusion in the treatment of three cases of acute thallium poisoningG de Groot, A N van Heijst, R G van Kesteren, et al.
Journal of Analytical Toxicology|March 25, 2000
Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysisD H van de Kerkhof, D de Boer, J H Thijssen, et al.
Clinical Pharmacokinetics|August 19, 1999
Intravesical drug delivery. Pharmacokinetic and clinical considerationsM S Highley, A T van Oosterom, R A Maes, et al.
European Journal of Pharmacology|July 4, 1995
The anxiolytic effects of flesinoxan, a 5-HT1A receptor agonist, are not related to its neuroendocrine effectsL Groenink, J Van der Gugten, P M Verdouw, et al.
The European Journal of Neuroscience|November 1, 1996
5-HT1A receptor agonist flesinoxan enhances Fos immunoreactivity in rat central amygdala, bed nucleus of the stria terminalis and hypothalamusJ C Compaan, L Groenink, J van der Gugten, et al.
Pageof 33